Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 10, 2025
Symeres, a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate ...
read more
Wednesday, September 10, 2025
Strides Pharma Science announced that its subsidiary, Strides Pharma Global Pte. Limited, Singapore, has entered into a strategic product development partnership with Kenox Pharmaceuticals, a contract development and manufacturing company ...
read more
Wednesday, September 10, 2025
GBI Biomanufacturing (GBI) announced a partnership with NanoRetinal, Inc. to develop and manufacture NAR-001, NanoRetinal's proprietary nanoparticle technology designed to restore and/or preserve vision in patients with Inherited Retinal Diseases (...
read more
Wednesday, September 10, 2025
BioIVT announced the company is expanding with new office space and a laboratory facility in Woodbury, New York.
read more
Tuesday, September 09, 2025
LGC Group opened its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD $100 million investment. The 203,000 ft² (17,200 m²) facility is one of the largest of its kind in the world and significantly expands ...
read more
Monday, September 08, 2025
SIRIO Pharma announced that its Ma’anshan facility in China has been granted a Certificate of GMP Compliance by the Therapeutic Goods Administration (TGA) of Australia.
read more
Monday, September 08, 2025
KBI Biopharma announced a collaboration to advance manufacturing of Infinimmune’s lead human monoclonal antibody (“IFX-101”) program.
read more
Monday, September 08, 2025
Made Scientific and Hemogenyx Pharma announced a manufacturing partnership to advance HG-CT-1, Hemogenyx's Chimeric Antigen Receptor T-cell (CAR-T) therapy and lead clinical program for the treatment of relapsed/refractory acute myeloid leukemia (r/r...
read more
Friday, September 05, 2025
FUJIFILM Biotechnologies announced the appointment of Samuel Hernandez, Ph.D., as senior vice president and site head for its College Station, Texas facility. With over two decades of biotechnology and pharmaceutical leadership experience, Dr. ...
read more
Friday, September 05, 2025
Mikart has signed a lease for new headquarters space at the Cumberland Center II, a premier office tower in the Cumberland-Galleria region of Northwest Atlanta. The newly leased facility, encompassing approximately 13,000 square feet, will house ...
read more
Wednesday, September 03, 2025
Julius Clinical, a clinical Contract Research Organization (CRO) with therapeutic expertise in CNS and Cardiometabolic indications, announced continued growth in bookings in these key therapeutic areas during the second quarter of 2025.
read more
Wednesday, September 03, 2025
Atelerix, a cell preservation and biological transport company, announced an agreement with Rodon Global, a freight company focused on clinical trials and drug discovery headquartered in South Africa. The collaboration comes at a pivotal time as ...
read more
Wednesday, September 03, 2025
Andelyn Biosciences has partnered with Tern Therapeutics to perform late-stage Process Performance Qualification (PPQ) manufacturing of Tern's TTX-381 program. TTX-381 is an investigational gene therapy targeting vision loss in children with CLN2 ...
read more
Wednesday, September 03, 2025
Aptamer Group ,a developer of synthetic binders for the life science industry, announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to ...
read more
Tuesday, September 02, 2025
CN Bio announced the expansion of its Contract Research Services (CRS) with new PhysioMimix® computational modeling tools. These capabilities have been developed to enhance Absorption, Distribution, Metabolism and Excretion (ADME) profiling, for ...
read more